ProShare Advisors
CBIO

ProShare Advisors’s Crescent Biopharma CBIO Stock Holding History

ProShare Advisors’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-122
Closed -$38K – 2095
2020
Q3 		$38K Buy
122
+6
+5% +$2.29K ﹤0.01% 1610
2020
Q2 		$43K Buy
+116
New +$32.8K ﹤0.01% 1630
2020
Q1 		– Sell
-140
Closed -$74K – 1335
2019
Q4 		$74K Sell
140
-15
-10% -$8.12K ﹤0.01% 1724
2019
Q3 		$67K Sell
155
-7
-4% -$4.5K ﹤0.01% 1578
2019
Q2 		$193K Sell
162
-22
-12% -$26.3K ﹤0.01% 1449
2019
Q1 		$229K Buy
184
+2
+1% +$2.29K ﹤0.01% 1390
2018
Q4 		$172K Sell
182
-35
-16% -$42.1K ﹤0.01% 1400
2018
Q3 		$313K Sell
217
-6
-3% -$9.07K ﹤0.01% 1330
2018
Q2 		$360K Buy
223
+64
+40% +$110K ﹤0.01% 1278
2018
Q1 		$258K Sell
159
-26
-14% -$54.1K ﹤0.01% 1406
2017
Q4 		$311K Buy
+185
New +$245K ﹤0.01% 1369

Other funds holding CBIO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $60.6B AUM 31.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return